SC 13G/A: Protagenic Therapeutics, Inc.\new

AI Summary

SC 13G/A filing by Protagenic Therapeutics, Inc.\new.

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.0001 — me of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 7436

Filing Documents

• armistice-ptix123123a2.htm (SC 13G/A) — 87KB
• 0001172661-24-001232.txt ( ) — 89KB

(a)Name of Issuer

Item 1. (a)Name of Issuer PROTAGENIC THERAPEUTICS, INC.

(b)Address of Issuer’s Principal

Item 1. (b)Address of Issuer’s Principal Executive Offices 149 Fifth Avenue, Suite 500 New York, New York 10010

(a)Names of Person Filing

Item 2. (a)Names of Person Filing: Armistice Capital, LLC Steven Boyd Collectively, the "Reporting Persons"

(b) Address of Principal Business Office

Item 2. (b) Address of Principal Business Office: Armistice Capital, LLC 510 Madison Avenue, 7th Floor New York, New York 10022 United Steven Boyd c/o Armistice Capital, LLC 510 Madison Avenue, 7th Floor New York, New York 10022 United

(c) Citizenship

Item 2. (c) Citizenship: Armistice Capital, LLC - Delaware Steven Boyd - United States of America

(d)Title of Class of Securities

Item 2. (d)Title of Class of Securities Common Stock, par value $0.0001 (“Shares”)

(e) CUSIP No

Item 2. (e) CUSIP No.: 74365N202 CUSIP No. 74365N202 SCHEDULE 13G/A Page 5 of 8 Pages

If

Item 3.If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) x An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) x A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) A group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J), please specify the type of institution: CUSIP No. 74365N202 SCHEDULE 13G/A Page 6 of 8 Pages Item 4.Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned as of December 31, 2023: Armistice Capital, LLC - 240,000 Steven Boyd - 240,000 (b) Percent of Class as of December 31, 2023: Armistice Capital, LLC - 5.13% Steven Boyd - 5.13% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote Armistice Capital, LLC - 0 Steven Boyd - 0 (ii) Shared power to vote or to direct the vote Armistice Capital, LLC - 240,000 Steven Boyd - 240,000 (iii) Sole power to dispose or to dir

View Full Filing

View this SC 13G/A filing on SEC EDGAR